Form 4/A for NRXS Neuraxis, INC
Accepted 2023-08-11 00:00:00 ET · period of report 2023-08-11 · accession 0000937556-23-000202 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2023-08-11 | 2023-08-11 | NRXS | MASIMO CORP | 10% | C - Cnv Deriv | — | +531.5K | 531.5K | New | — |
| DMA | 2023-08-11 | 2023-08-11 | NRXS | MASIMO CORP | 10% | C - Cnv Deriv | $0.00 | -120.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-11 | C | A | 531,548 | — | 531,548 | D | — | — | (F1) Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date. |
| 2 | Derivative | Pre-Funded Warrant, Common Stock (Right to Buy) | 2023-08-11 | C | A | 289,779 | $0.00 | 289,779 | D | $0.00 · — to — | 289,779 Common Stock | (F2) The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock. |
| 3 | Derivative | Series A Preferred Stock | 2023-08-11 | C | D | 265,774 | $0.00 | 0 | D | — · — to — | 531,548 Common Stock | (F1) Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date. |
| 4 | Derivative | Pre-Funded Warrant, Series A Preferred Stock (Right to Buy) | 2023-08-11 | C | D | 144,890 | $0.00 | 0 | D | $0.00 · — to — | 144,890 Series A Preferred Stock | (F2) The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock. |